ADAR1 Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.53M	Hold	53,125	–	–	0.23%	63
2025 Q1	$1.78M	Hold	53,125	–	–	0.33%	58
2024 Q4	$2.72M	Sell	53,125 -35,300	-40%	-$1.8M	0.54%	38
2024 Q3	$4.52M	Buy	88,425 +13,575	+18%	+$694K	0.73%	28
2024 Q2	$3.35M	Buy	+74,850	New	+$3.35M	0.63%	24